ALISSA GORDON: Open Payments
NPI 1326563917 · ROCK ISLAND, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 10 payments from 6 companies in 2025. Trend: 2023 $167 · 2024 $182 · 2025 $209
Food & beverage: $209
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $65 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Abbott Laboratories | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: ARISTADA, ABILIFY ASIMTUFII, AREXVY, SHINGRIX, FREESTYLE LIBRE 3, CAPLYTA, LYBALVI.
Industry payments across IL — which companies pay providers there.
